Valeant to sell medical products biz to Haitong Zhonghua fund for $190m

The headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec in this file picture taken November 9, 2015. Source: Christinne Muschi/File Photo/Reuters

Valeant Pharmaceuticals International Inc said on Monday it would sell its Obagi Medical Products business for $190 million in cash, as part of the Canadian drugmaker’s efforts to cut down its debt.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe